Terms: = Colorectal cancer AND CEACAM5, CEA AND Clinical Outcome
60 results:
1. Proinflammatory and cancer-Promoting Pathobiont
Cavallucci V; Palucci I; Fidaleo M; Mercuri A; Masi L; Emoli V; Bianchetti G; Fiori ME; Bachrach G; Scaldaferri F; Maulucci G; Delogu G; Pani G
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139097
[TBL] [Abstract] [Full Text] [Related]
2. Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable colorectal cancer Prognosis.
Cui C; Zhang R; Gu F; Pei Y; Sun L; Huang Y; Niu G; Li J
J Immunol Res; 2022; 2022():1336509. PubMed ID: 35664357
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract] [Full Text] [Related]
4. Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer.
Jia N; Chang L; Gao X; Shi X; Dou X; Guan M; Shao Y; Li N; Cheng Y; Ying H; Sun Z; Zhou Y; Zhao L; Zhou J; Bai C
BMC Cancer; 2021 Jul; 21(1):845. PubMed ID: 34294055
[TBL] [Abstract] [Full Text] [Related]
5. Predictive factors of complete pathological response in patients with locally advanced rectal cancer.
Engel RM; Oliva K; Koulis C; Yap R; McMurrick PJ
Int J Colorectal Dis; 2020 Sep; 35(9):1759-1767. PubMed ID: 32474708
[TBL] [Abstract] [Full Text] [Related]
6. The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision.
Wang X; Chen G; Zhang Y; Ghareeb WM; Yu Q; Zhu H; Lu X; Huang Y; Huang S; Hou D; Chi P
Eur J Surg Oncol; 2020 Jun; 46(6):1118-1123. PubMed ID: 32113887
[TBL] [Abstract] [Full Text] [Related]
7. Pharmacokinetics of mitomycin-c lipidic prodrug entrapped in liposomes and clinical correlations in metastatic colorectal cancer patients.
Gabizon AA; Tahover E; Golan T; Geva R; Perets R; Amitay Y; Shmeeda H; Ohana P
Invest New Drugs; 2020 Oct; 38(5):1411-1420. PubMed ID: 31955309
[TBL] [Abstract] [Full Text] [Related]
8. Neo-adjuvant Chemotherapy-Induced Neutropenia Is Associated with Histological Responses and outcomes after the Resection of colorectal Liver Metastases.
Chen Q; Wu C; Zhao H; Wu J; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J
J Gastrointest Surg; 2020 Mar; 24(3):659-670. PubMed ID: 30937711
[TBL] [Abstract] [Full Text] [Related]
9. Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial.
Diefenhardt M; Hofheinz RD; Martin D; Beißbarth T; Arnold D; Hartmann A; von der Grün J; Grützmann R; Liersch T; Ströbel P; Grabenbauer GG; Rieger M; Fietkau R; Graeven U; Weitz J; Folprecht G; Ghadimi M; Rödel F; Rödel C; Fokas E;
Int J Cancer; 2019 Oct; 145(8):2282-2291. PubMed ID: 30868576
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic significance of ceacam5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer.
Messaritakis I; Sfakianaki M; Papadaki C; Koulouridi A; Vardakis N; Koinis F; Hatzidaki D; Georgoulia N; Kladi A; Kotsakis A; Souglakos J; Georgoulias V
Cancer Chemother Pharmacol; 2018 Nov; 82(5):767-775. PubMed ID: 30094617
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy, Safety, and Cost of Therapy of the Traditional Chinese Medicine, Catalpol, in Patients Following Surgical Resection for Locally Advanced Colon cancer.
Fei B; Dai W; Zhao S
Med Sci Monit; 2018 May; 24():3184-3192. PubMed ID: 29763415
[TBL] [Abstract] [Full Text] [Related]
12. Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients.
Zhang L; Zhao J; Yu B; Song X; Sun G; Han L; Wang L; Dong S
Cancer Genet; 2017 Dec; 218-219():51-57. PubMed ID: 29153096
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of gene expression EGFR and KRAS, microRNA-21 and microRNA-203 in patients with colon and rectal cancer and correlation with clinical outcome and prognostic factors.
Carvalho TI; Novais PC; Lizarte FS; Sicchieri RD; Rosa MS; Carvalho CA; Tirapelli DP; Peria FM; Rocha JJ; Féres O
Acta Cir Bras; 2017 Mar; 32(3):243-250. PubMed ID: 28403349
[TBL] [Abstract] [Full Text] [Related]
14. High expression of atonal homolog 8 predicts a poor clinical outcome in patients with colorectal cancer and contributes to tumor progression.
Ye M; He Y; Lin H; Yang S; Zhou Y; Zhou L; Zhong J; Lu G; Zheng J; Xue ZX; Cai ZZ
Oncol Rep; 2017 May; 37(5):2955-2963. PubMed ID: 28393252
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of regulator of G-protein signaling 6 in colorectal cancer.
Luo Y; Qin SL; Yu MH; Mu YF; Wang ZS; Zhong M
Biomed Pharmacother; 2015 Dec; 76():147-52. PubMed ID: 26653562
[TBL] [Abstract] [Full Text] [Related]
16. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract] [Full Text] [Related]
17. Survival in Resected Stage II colorectal cancer Is Dependent on Tumor Depth, Vascular Invasion, Postoperative cea Level, and The Number of Examined Lymph Nodes.
Tsai HL; Huang CW; Chen CW; Yeh YS; Ma CJ; Wang JY
World J Surg; 2016 Apr; 40(4):1002-9. PubMed ID: 26560149
[TBL] [Abstract] [Full Text] [Related]
18. The Prognostic Value of Preoperative Serum cea and CA19-9 Values in Stage I-III colorectal cancer.
Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X
Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155
[TBL] [Abstract] [Full Text] [Related]
19. cea/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.
Oberst MD; Fuhrmann S; Mulgrew K; Amann M; Cheng L; Lutterbuese P; Richman L; Coats S; Baeuerle PA; Hammond SA
MAbs; 2014; 6(6):1571-84. PubMed ID: 25484061
[TBL] [Abstract] [Full Text] [Related]
20. cea change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
[TBL] [Abstract] [Full Text] [Related]
[Next]
